???global.info.a_carregar???
Positions/functions: Medical geneticist (2007 – present) Head of molecular genetic routine diagnostic lab (2008 – 2015) Principal investigator (2008 – present) University assistant professor (2009 – present) Coordinated the set up and headed a molecular genetic diagnostic laboratory (2008-15, Genomed, IMM, Faculty of Medicine, University of Lisbon, www.genomed.pt). Introduced >300 new genetic tests. Increased the number of analyses from 5/month to ~150/month. Obtained ISO 9001-2008 certification. Principle investigator of research projects, incl. scientific and financial leadership. Leader of international collaborations (USA, Germany, Spain, Brazil, Finland, Australia). Coordinate and supervise the daily work of technicians and students. Medical geneticist at the Portuguese Reference Centre for Lysosomal Storage Diseases. Research interest in Rare diseases, Lysosomal diseases, Rheumatology, Neurology. Teaching Human Genetics at University of Algarve (2009-2012), University of Lisbon (2013-present) and University of Minho/Braga (2015-present). Awards: The 2006 Scientific Award of the Austrian Society of Human Genetics Prémio Roche 2013: Yearly Scientific Award of the Portuguese Society of Nephrology Total number of papers: 63 Total citations: 631 Current projects as principal investigator: 2 (total: 300.000 EUR) Current projects as collaborator: 4 Invited speaker at Congresses: >20 Selected papers: Guedes LC, ..., Miltenberger-Miltenyi G. Serum lipid alterations in GBA-associated Parkinson's disease. Parkinsonism Relat Disord. 2017; 44:58-65. (IF [2016] 4.484, 22 citations) Miltenberger-Miltenyi G, et al. C9orf72 expansion is associated with accelerated decline of respiratory function and decreased survival in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2019 Jan;90(1):118-120.. (IF [2019] 8.272, 2 citations) Miltenberger-Miltenyi G, Cruz-Machado AR, Saville J, Conceição VA, Calado A, Lopes I, Fuller M, Fonseca JE. Increased monohexosylceramide levels in the serum of established Rheumatoid Arthritis patients. (accepted in Rheumatology, IF [2018] 5.149)
Identification

Personal identification

Full name
Gabriel Miltenberger-Miltenyi

Citation names

  • Miltenberger-Miltenyi, Gabriel

Author identifiers

Ciência ID
AE16-3A8D-0392
ORCID iD
0000-0003-0224-1281

Knowledge fields

  • Medical and Health Sciences - Basic Medicine - Human Genetics
  • Medical and Health Sciences - Medical Biotechnology - Gene-based Diagnostics and Therapeutic Interventions
  • Medical and Health Sciences - Basic Medicine - Neurosciences
  • Medical and Health Sciences - Clinical Medicine - Rheumatology
  • Medical and Health Sciences - Clinical Medicine - Cardiac and Cardiovascular Systems

Languages

Language Speaking Reading Writing Listening Peer-review
English Advanced (C1) Advanced (C1) Advanced (C1) Advanced (C1)
German Advanced (C1) Advanced (C1) Advanced (C1) Advanced (C1)
Hungarian Advanced (C1) Advanced (C1) Advanced (C1) Advanced (C1)
Portuguese Advanced (C1) Advanced (C1) Advanced (C1) Advanced (C1)
Education
Degree Classification
2002/10/09
Concluded
PATHOPHYSIOLOGIC AND GENETIC ASPECTS OF ARTERIAL REMODELING BY ELEVATED BLOOD PRESSURE– STUDIES IN UREMIC AND PULMONARY HYPERTENSIVE PATIENTS (Doktor (PhD))
Semmelweis Egyetem, Hungary
"Pathopysiologic and genetic aspects of arterial remodeling by elevated blood pressure- studies in uremic and pulmonary hypertensive patients" (THESIS/DISSERTATION)
summa cum laude
1996/09/22
Concluded
Orthostatic proteinuria in Children (Doctor)
Semmelweis Egyetem, Hungary
"Orthostatic proteinuria in the Childhood" (THESIS/DISSERTATION)
cum laude
Affiliation

Science

Category
Host institution
Employer
2008/02/18 - Current Principal Investigator (Research) Instituto de Medicina Molecular João Lobo Antunes, Portugal

Teaching in Higher Education

Category
Host institution
Employer
2013/03/01 - Current Assistant Professor (University Teacher) Universidade de Lisboa Faculdade de Medicina, Portugal

Others

Category
Host institution
Employer
2003 - Current Medical doctor Medizinische Universität Innsbruck, Austria
2000 - Current PhD student Ruprecht Karls Universität Heidelberg Medizinische Fakultät Heidelberg, Germany
1997 - Current PhD student Ruprecht Karls Universität Heidelberg Medizinische Fakultät Heidelberg, Germany
1996/09/01 - Current medical doctor and PhD student Semmelweis Egyetem 1 számú Gyermekgyógyászati Klinika, Hungary
1996 - Current PhD student Ruprecht Karls Universität Heidelberg, Germany
2008/02/01 - 2015/01/31 Head of genetic diagnostic lab, principal investigator, medical doctor Instituto de Medicina Molecular João Lobo Antunes, Portugal
Projects

Grant

Designation Funders
2018/09/01 - Current Fabry disease genetic studies
IIR-PRT-001458
Principal investigator
Ongoing
2012/06 - 2015/12 BIOMARKADP -Biomarkers for Alzheimer's disease and Parkinson's disease Stichting Weten
2013/05 - 2015/10 Glucocerebrosidase in Parkinson's disease: from risk factor to biomarker
Principal investigator
Stichting Weten
Outputs

Publications

Journal article
  1. van der Ende EL; Xiao M; Xu D; Poos JM; Panman JL; Jiskoot LC; Meeter LH; et al. "Neuronal pentraxin 2: a synapse-derived CSF biomarker in genetic frontotemporal dementia.". Journal of neurology, neurosurgery, and psychiatry (2020): http://europepmc.org/abstract/med/32273328.
    10.1136/jnnp-2019-322493
  2. Le Blanc G; Jetté Pomerleau V; McCarthy J; Borroni B; van Swieten J; Galimberti D; Sanchez-Valle R; et al. "Faster Cortical Thinning and Surface Area Loss in Presymptomatic and Symptomatic C9orf72 Repeat Expansion Adult Carriers.". Annals of neurology (2020): http://europepmc.org/abstract/med/32285980.
    10.1002/ana.25748
  3. Azevedo O; Gago MF; Miltenberger-Miltenyi G; Robles AR; Costa MA; Pereira O; Vide AT; et al. "Natural history of the late-onset phenotype of Fabry disease due to the p.F113L mutation.". Molecular genetics and metabolism reports (2020): http://europepmc.org/abstract/med/32099817.
    10.1016/j.ymgmr.2020.100565
  4. Gago MF; Azevedo O; Guimarães A; Teresa Vide A; Lamas NJ; Oliveira TG; Gaspar P; et al. "Parkinson's Disease and Fabry Disease: Clinical, Biochemical and Neuroimaging Analysis of Three Pedigrees.". Journal of Parkinson's disease (2020): http://europepmc.org/abstract/med/31594250.
    10.3233/JPD-191704
  5. Heller C; Foiani MS; Moore K; Convery R; Bocchetta M; Neason M; Cash DM; et al. "Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia.". Journal of neurology, neurosurgery, and psychiatry (2020): http://europepmc.org/abstract/med/31937580.
    10.1136/jnnp-2019-321954
  6. Gabriel Miltenberger-Miltenyi; Ana Rita Cruz-Machado; Jennifer Saville; Vasco A Conceição; Ângelo Calado; Inês Lopes; Maria Fuller; João Eurico Fonseca. "Increased monohexosylceramide levels in the serum of established rheumatoid arthritis patients". Rheumatology (2019): https://doi.org/10.1093/rheumatology/kez545.
    10.1093/rheumatology/kez545
  7. van der Ende EL; Meeter LH; Poos JM; Panman JL; Jiskoot LC; Dopper EGP; Papma JM; et al. "Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study.". The Lancet. Neurology (2019): http://europepmc.org/abstract/med/31701893.
    10.1016/s1474-4422(19)30354-0
  8. Moore KM; Nicholas J; Grossman M; McMillan CT; Irwin DJ; Massimo L; Van Deerlin VM; et al. "Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study.". The Lancet. Neurology (2019): http://europepmc.org/abstract/med/31810826.
    10.1016/s1474-4422(19)30394-1
  9. Azevedo O; Marques N; Craveiro N; Pereira AR; Antunes H; Reis L; Guerreiro RA; et al. "Screening for Fabry disease in patients with left ventricular noncompaction.". Revista Portuguesa De Cardiologia (2019): http://europepmc.org/abstract/med/31901299.
    10.1016/j.repc.2019.02.014
  10. Carvalho Silva DM; Marques N; Azevedo O; Miltenberger-Miltenyi G; Bento D; Guedes J; Azevedo P; et al. "p.G360R Is a Pathogenic GLA Gene Mutation Responsible for a Classic Phenotype of Fabry Disease.". Cardiology (2019): http://europepmc.org/abstract/med/31634893.
    10.1159/000502437
  11. Tavares TP; Mitchell DGV; Coleman K; Shoesmith C; Bartha R; Cash DM; Moore KM; et al. "Ventricular volume expansion in presymptomatic genetic frontotemporal dementia.". Neurology (2019): http://europepmc.org/abstract/med/31578297.
    10.1212/WNL.0000000000008386
  12. Ribeiro S; Coelho L; Puentes K; Miltenberger-Miltenyi G; Faria B; Calvo L; Primo J; Sanfins V; Lourenço A. "Post mortem genetic test, the clinical diagnosis is not fade with the death of the patient.". Revista Portuguesa De Cardiologia (2019): http://europepmc.org/abstract/med/31522937.
    10.1016/j.repc.2018.12.004
  13. Azevedo O; Gal A; Faria R; Gaspar P; Miltenberger-Miltenyi G; Gago MF; Dias F; et al. "Founder effect of Fabry disease due to p.F113L mutation: Clinical profile of a late-onset phenotype.". Molecular genetics and metabolism (2019): http://europepmc.org/abstract/med/31519519.
    10.1016/j.ymgme.2019.07.012
  14. Costa MR; Gromicho M; Pronto-Laborinho AC; Miltenberger Miltényi G; de Carvalho M. "Novel TBK1 LoF variant in a family with upper motor neuron predominant motor neuron disease.". Journal of the neurological sciences (2019): http://europepmc.org/abstract/med/31276859.
    10.1016/j.jns.2019.06.029
  15. Gabriel Miltenberger-Miltenyi; Vasco A Conceição; Marta Gromicho; Ana Catarina Pronto-Laborinho; Susana Pinto; Peter M Andersen; Mamede de Carvalho. "C9orf72 expansion is associated with accelerated decline of respiratory function and decreased survival in amyotrophic lateral sclerosis". Journal of Neurology, Neurosurgery & Psychiatry 90 1 (2019): 118-120. https://doi.org/10.1136/jnnp-2018-318032.
    10.1136/jnnp-2018-318032
  16. Baradaran-Heravi Y; Dillen L; Nguyen HP; Van Mossevelde S; Baets J; De Jonghe P; Engelborghs S; et al. "No supportive evidence for TIA1 gene mutations in a European cohort of ALS-FTD spectrum patients.". Neurobiology of aging (2018): http://europepmc.org/abstract/med/29886022.
    10.1016/j.neurobiolaging.2018.05.005
  17. Philtjens S; Van Mossevelde S; van der Zee J; Wauters E; Dillen L; Vandenbulcke M; Vandenberghe R; et al. "Rare nonsynonymous variants in SORT1 are associated with increased risk for frontotemporal dementia.". Neurobiology of aging (2018): http://europepmc.org/abstract/med/29555433.
    10.1016/j.neurobiolaging.2018.02.011
  18. Pinho R; Guedes LC; Soreq L; Lobo PP; Mestre T; Coelho M; Rosa MM; et al. "Correction: Gene Expression Differences in Peripheral Blood of Parkinson's Disease Patients with Distinct Progression Profiles.". PloS one (2017): http://europepmc.org/abstract/med/29284061.
    10.1371/journal.pone.0190552
  19. Guedes LC; Chan RB; Gomes MA; Conceição VA; Machado RB; Soares T; Xu Y; et al. "Serum lipid alterations in GBA-associated Parkinson's disease.". Parkinsonism & related disorders (2017): http://europepmc.org/abstract/med/28890071.
    10.1016/j.parkreldis.2017.08.026
  20. De Carvalho M; Ryczkowski A; Andersen P; Gromicho M; Grosskreutz J; Kuzma-Kozakiewicz M; Petri S; Piotrkiewicz M; Miltenberger Miltenyi G. "International Survey of ALS Experts about Critical Questions for Assessing Patients with ALS.". Amyotrophic lateral sclerosis & frontotemporal degeneration (2017): http://europepmc.org/abstract/med/28705085.
    10.1080/21678421.2017.1349150
  21. Premi E; Grassi M; van Swieten J; Galimberti D; Graff C; Masellis M; Tartaglia C; et al. "Cognitive reserve and TMEM106B genotype modulate brain damage in presymptomatic frontotemporal dementia: a GENFI study.". Brain : a journal of neurology (2017): http://europepmc.org/abstract/med/28460069.
    10.1093/brain/awx103
  22. Brito D; Magalhães A; Cortez-Dias N; Miltenberger-Miltenyi G. "Rare Association of two Genetic Causes of Sudden Death in a Young Survivor.". Arquivos brasileiros de cardiologia (2017): http://europepmc.org/abstract/med/28327871.
    10.5935/abc.20170016
  23. Azevedo O; Gago M; Miltenberger-Miltenyi G; Gaspar P; Sousa N; Cunha D. "Mild Left Ventricular Hypertrophy Unravels a Novel Nonsense Mutation of the GLA Gene Associated with the Classical Phenotype of Fabry Disease.". Cardiology (2017): http://europepmc.org/abstract/med/28152533.
    10.1159/000455117
  24. van der Zee J; Gijselinck I; Van Mossevelde S; Perrone F; Dillen L; Heeman B; Bäumer V; et al. "TBK1 Mutation Spectrum in an Extended European Patient Cohort with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis.". Human mutation (2017): http://europepmc.org/abstract/med/28008748.
    10.1002/humu.23161
  25. Pinho R; Guedes LC; Soreq L; Lobo PP; Mestre T; Coelho M; Rosa MM; et al. "Gene Expression Differences in Peripheral Blood of Parkinson's Disease Patients with Distinct Progression Profiles.". PloS one (2016): http://europepmc.org/abstract/med/27322389.
    10.1371/journal.pone.0157852
  26. van der Zee J; Van Langenhove T; Kovacs GG; Dillen L; Deschamps W; Engelborghs S; Matej R; et al. "Rare mutations in SQSTM1 modify susceptibility to frontotemporal lobar degeneration.". Acta neuropathologica (2014): http://europepmc.org/abstract/med/24899140.
    10.1007/s00401-014-1298-7
  27. Machado MV; Janeiro A; Miltenberger-Miltenyi G; Cortez-Pinto H. "Genetic polymorphisms of proangiogenic factors seem to favor hepatocellular carcinoma development in alcoholic cirrhosis.". European journal of gastroenterology & hepatology (2014): http://europepmc.org/abstract/med/24445728.
    10.1097/meg.0000000000000044
  28. Brito D; Miltenberger-Miltenyi G; Moldovan O; Navarro C; Madeira HC. "Cardiac Anderson-Fabry disease: lessons from a 25-year-follow up.". Revista Portuguesa De Cardiologia (2014): http://europepmc.org/abstract/med/24830310.
    10.1016/j.repc.2013.10.014
  29. Madruga Dias JA; Rosa RS; Perpétuo I; Rodrigues AM; Janeiro A; Costa MM; Gaião L; et al. "Pachydermoperiostosis in an African patient caused by a Chinese/Japanese SLCO2A1 mutation-Case report and review of literature.". (2013): http://europepmc.org/abstract/med/24012041.
    10.1016/j.semarthrit.2013.07.015
  30. van der Zee J; Gijselinck I; Dillen L; Van Langenhove T; Theuns J; Engelborghs S; Philtjens S; et al. "A pan-European study of the C9orf72 repeat associated with FTLD: geographic prevalence, genomic instability, and intermediate repeats.". (2013): http://europepmc.org/abstract/med/23111906.
    10.1002/humu.22244
  31. Silva D; Miltenberger-Miltenyi G; Correia MJ; Diogo AN. "Novel mutation in the KCNH2 gene associated with long QT syndrome.". (2013): http://europepmc.org/abstract/med/23351921.
    10.1016/j.repc.2012.06.012
  32. Pires C; Coelho M; Valadas A; Barroso C; Pimentel J; Martins M; Duyckaerts C; et al. "Phenotypic variability of familial and sporadic Progranulin p.Gln257Profs*27 mutation.". (2013): http://europepmc.org/abstract/med/23813535.
    10.3233/JAD-130146
  33. Dijkstra, J.R.; Heideman, D.A.M.; Meijer, G.A.; Boers, J.E.; 'T Hart, N.A.; Diebold, J.; Hirschmann, A.; et al. "KRAS mutation analysis on low percentage of colon cancer cells: The importance of quality assurance". Virchows Archiv 462 1 (2013): 39-46. http://www.scopus.com/inward/record.url?eid=2-s2.0-84872301767&partnerID=MN8TOARS.
    10.1007/s00428-012-1356-2
  34. Michou L; Conceição N; Morissette J; Gagnon E; Miltenberger-Miltenyi G; Siris ES; Brown JP; Cancela ML. "Genetic association study of UCMA/GRP and OPTN genes (PDB6 locus) with Paget's disease of bone.". (2012): http://europepmc.org/abstract/med/22796589.
    10.1016/j.bone.2012.06.028
  35. Andreasson A; Sulaiman L; do Vale S; Martins JM; Ferreira F; Miltenberger-Miltenyi G; Batista L; et al. "Molecular characterization of parathyroid tumors from two patients with hereditary colorectal cancer syndromes.". (2012): http://europepmc.org/abstract/med/22395475.
    10.1007/s10689-012-9520-z
  36. Brito D; Miltenberger-Miltenyi G; Vale Pereira S; Silva D; Diogo AN; Madeira H. "Sarcomeric hypertrophic cardiomyopathy: genetic profile in a Portuguese population.". (2012): http://europepmc.org/abstract/med/22857948.
    10.1016/j.repc.2011.12.020
  37. Jorge C; Marques JS; Miltenberger-Miltényi G; Pinto FJ. "Hypertrophic cardiomyopathy or non-compaction? How the first impression can be wrong.". (2012): http://europepmc.org/abstract/med/22078399.
    10.1016/j.ijcard.2011.10.110
  38. Chester C; de Carvalho M; Miltenberger G; Pereira S; Dillen L; van der Zee J; van Broeckhoven C; de Mendonça A. "Rapidly progressive frontotemporal dementia and bulbar amyotrophic lateral sclerosis in Portuguese patients with C9orf72 mutation.". Amyotrophic lateral sclerosis & frontotemporal degeneration (2012): http://europepmc.org/abstract/med/22742426.
    10.3109/17482968.2012.690418
  39. Neutel D; Miltenberger-Miltenyi G; Silva I; de Carvalho M. "Chorea-acanthocytosis presenting as motor neuron disease.". (2012): http://europepmc.org/abstract/med/22246890.
    10.1002/mus.22269
  40. Taipa R; Tuna A; Damásio J; Pinto PS; Cavaco S; Pereira S; Milterberger-Miltenyi G; Galimberti D; Melo-Pires M. "Clinical, neuropathological, and genetic characteristics of the novel IVS9+1delG GRN mutation in a patient with frontotemporal dementia.". Journal of Alzheimer's disease : JAD (2012): http://europepmc.org/abstract/med/22366770.
    10.3233/jad-2012-112084
  41. Neutel, D.; Miltenberger-Miltenyi, G.; Silva, I.; de Carvalho, M.. "Chorea-acanthocytosis presenting as motor neuron disease". Muscle and Nerve 45 2 (2012): 293-295. http://www.scopus.com/inward/record.url?eid=2-s2.0-84855857600&partnerID=MN8TOARS.
    10.1002/mus. 22269
  42. Jorge C; Marques JS; Veiga A; Nóbrega J; Cruz J; Peralta R; Correia MJ; et al. "[Novel mutation in long QT syndrome in a patient with prior diagnosis of epilepsy].". (2011): http://europepmc.org/abstract/med/22104571.
    10.1016/j.repc.2011.10.003
  43. de Oliveira RM; Marijanovic Z; Carvalho F; Miltényi GM; Matos JE; Tenreiro S; Oliveira S; et al. "Impaired proteostasis contributes to renal tubular dysgenesis.". PloS one (2011): http://europepmc.org/abstract/med/21695262.
    10.1371/journal.pone.0020854
  44. Carvalho FA; Connell S; Miltenberger-Miltenyi G; Pereira SV; Tavares A; Ariëns RA; Santos NC. "Atomic force microscopy-based molecular recognition of a fibrinogen receptor on human erythrocytes.". (2010): http://europepmc.org/abstract/med/20731444.
    10.1021/nn1009648
  45. Cardoso BM; Dupont J; Castanhinha S; Ejarque-Albuquerque M; Pereira S; Miltenberger-Miltenyi G; Oliveira G. "Cleidocranial dysplasia with severe parietal bone dysplasia: a new (p.Val124Serfs) RUNX2 mutation.". (2010): http://europepmc.org/abstract/med/20299969.
    10.1097/MCD.0b013e32833593a1
  46. Antunes J; Filipe P; André M; Fraga A; Miltenyi G; Marques Gomes M. "Livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity (4G/4G) and prothrombin G20210A heterozygosity: response to t-PA therapy.". Acta dermato-venereologica (2010): http://europepmc.org/abstract/med/20107738.
    10.2340/00015555-0760
  47. Miltenberger-Miltenyi G; Schwarzbraun T; Löscher WN; Wanschitz J; Windpassinger C; Duba HC; Seidl R; et al. "Identification and in silico analysis of 14 novel GJB1, MPZ and PMP22 gene mutations.". (2009): http://europepmc.org/abstract/med/19259128.
    10.1038/ejhg.2009.29
  48. Auer-Grumbach M; Fischer C; Papic L; John E; Plecko B; Bittner RE; Bernert G; et al. "Two novel mutations in the GDAP1 and PRX genes in early onset Charcot-Marie-Tooth syndrome.". Neuropediatrics (2008): http://europepmc.org/abstract/med/18504680.
    10.1055/s-2008-1077085
  49. Rohkamm B; Reilly MM; Lochmüller H; Schlotter-Weigel B; Barisic N; Schöls L; Nicholson G; et al. "Further evidence for genetic heterogeneity of distal HMN type V, CMT2 with predominant hand involvement and Silver syndrome.". (2007): http://europepmc.org/abstract/med/17663003.
    10.1016/j.jns.2007.06.047
  50. Miltenberger-Miltenyi G; Janecke AR; Wanschitz JV; Timmerman V; Windpassinger C; Auer-Grumbach M; Löscher WN. "Clinical and electrophysiological features in Charcot-Marie-Tooth disease with mutations in the NEFL gene.". (2007): http://europepmc.org/abstract/med/17620486.
    10.1001/archneur.64.7.966
  51. Finsterer J; Miltenberger G; Rauschka H; Janecke A. "Novel C59T leader peptide mutation in the MPZ gene associated with late-onset, axonal, sensorimotor polyneuropathy.". European journal of neurology (2006): http://europepmc.org/abstract/med/16987171.
    10.1111/j.1468-1331.2006.01479.x
  52. Miltenberger-Miltenyi, G.; Szonyi, L.; Balogh, L.; Utermann, G.; Janecke, A.R.. "Mutation spectrum of type I glycogen storage disease in Hungary". Journal of Inherited Metabolic Disease 28 6 (2005): 939-944. http://www.scopus.com/inward/record.url?eid=2-s2.0-31644448422&partnerID=MN8TOARS.
    10.1007/s10545-005-0186-7
  53. Grünig E; Koehler R; Miltenberger-Miltenyi G; Zimmermann R; Gorenflo M; Mereles D; Arnold K; et al. "Primary pulmonary hypertension in children may have a different genetic background than in adults.". (2004): http://europepmc.org/abstract/med/15295086.
    10.1203/01.PDR.0000139481.20847.D0
  54. Miltenberger-Miltenyi G; Laccone F. "Mutations and polymorphisms in the human methyl CpG-binding protein MECP2.". (2003): http://europepmc.org/abstract/med/12872250.
    10.1002/humu.10243
  55. Rindermann M; Grünig E; von Hippel A; Koehler R; Miltenberger-Miltenyi G; Mereles D; Arnold K; et al. "Primary pulmonary hypertension may be a heterogeneous disease with a second locus on chromosome 2q31.". (2003): http://europepmc.org/abstract/med/12821254.
    10.1016/S0735-1097(03)00491-1
  56. Janssen B; Rindermann M; Barth U; Miltenberger-Miltenyi G; Mereles D; Abushi A; Seeger W; et al. "Linkage analysis in a large family with primary pulmonary hypertension: genetic heterogeneity and a second primary pulmonary hypertension locus on 2q31-32.". (2002): http://europepmc.org/abstract/med/11893685.
    10.1378/chest.121.3_suppl.54S
  57. Grünig E; Mereles D; Arnold K; Benz A; Olschewski H; Miltenberger-Miltenyi G; Borst MM; et al. "Primary pulmonary hypertension is predominantly a hereditary disease.". Chest (2002): http://europepmc.org/abstract/med/11893705.
    10.1378/chest.121.3_suppl.81s
  58. Grünig, E.; Mereles, D.; Arnold, K.; Benz, A.; Olschewski, H.; Miltenberger-Miltenyi, G.; Borst, M.M.; et al. "Primary pulmonary hypertension is predominantly a hereditary disease". Chest 121 3 (2002): http://www.scopus.com/inward/record.url?eid=2-s2.0-0036126483&partnerID=MN8TOARS.
  59. Janssen, B.; Rindermann, M.; Barth, U.; Miltenberger-Miltenyi, G.; Mereles, D.; Abushi, A.; Seeger, W.; et al. "Linkage analysis in a large family with primary pulmonary hypertension: Genetic heterogeneity and a second primary pulmonary hypertension locus on 2q31-32". Chest 121 3 (2002): http://www.scopus.com/inward/record.url?eid=2-s2.0-0036128018&partnerID=MN8TOARS.
  60. Amann K; Miltenberger-Miltenyi G; Simonoviciene A; Koch A; Orth S; Ritz E. "Remodeling of resistance arteries in renal failure: effect of endothelin receptor blockade.". Journal of the American Society of Nephrology : JASN (2001): http://europepmc.org/abstract/med/11562402.
  61. Amann, K.; Miltenberger-Miltenyi, G.; Simonoviciene, A.; Koch, A.; Orth, S.; Ritz, E.. "Remodeling of resistance arteries in renal failure: Effect of endothelin receptor blockade". Journal of the American Society of Nephrology 12 10 (2001): 2040-2050. http://www.scopus.com/inward/record.url?eid=2-s2.0-0034836302&partnerID=MN8TOARS.
  62. Amann, K.; Buzello, M.; Simonaviciene, A.; Miltenberger-Miltenyi, G.; Koch, A.; Nabokov, A.; Gross, M.-L.; et al. "Capillary/myocyte mismatch in the heart in renal failure - A role for erythropoietin?". Nephrology Dialysis Transplantation 15 7 (2000): 964-969. http://www.scopus.com/inward/record.url?eid=2-s2.0-0034130587&partnerID=MN8TOARS.
  63. Ritz, E.; Miltenberger-Miltenyi, G.; Rychlik, I.; Fliser, D.. "Endstage renal failure in diabetes type II - A silent epidemic". Nephrology 4 5-6 (1998): 299-302. http://www.scopus.com/inward/record.url?eid=2-s2.0-0032454342&partnerID=MN8TOARS.
  64. Ritz, E.; Rychlík, I.; Miltenberger-Miltenyi, G.. "Optimizing antihypertensive therapy in patients with diabetic nephropathy". Journal of Hypertension, Supplement 16 7 (1998): http://www.scopus.com/inward/record.url?eid=2-s2.0-0031753741&partnerID=MN8TOARS.
  65. Ritz, E.; Miltenberger-Miltenyi, G.; Wagner, J.; Rychlik, I.. "Diabetes - Renal function - What are the special problems?". Basic Research in Cardiology, Supplement 93 1 (1998): 125-130. http://www.scopus.com/inward/record.url?eid=2-s2.0-0031793105&partnerID=MN8TOARS.
  66. Rychlik, I.; Miltenberger-Miltenyi, G.; Ritz, E.. "The drama of the continuous increase in end-stage renal failure in patients with type II diabetes mellitus". Nephrology Dialysis Transplantation 13 SUPPL. 8 (1998): 6-10. http://www.scopus.com/inward/record.url?eid=2-s2.0-0031723833&partnerID=MN8TOARS.
Activities

Supervision

Thesis Title
Role
Degree Subject (Type)
Institution / Organization
2019/04/01 - 2020 Azhar Orynbek, Molecular Biology, University of Debrecen, Faculty of Medicine, Department of Human Genetics, Development and Initial Feasibility Testing of Hpap_V1 an Algorithm to Predict Individual Risk for Psoriasis, a Complex Genetic Disease
Co-supervisor
2013/03/01 - 2014 Alexandra Oliveira, Biologia Clínica Laboratorial, Universidade de Trás-os-Montes e Alto Douro, Further studies on the molecular background of familial dementia – genotype-phenotype associations.
Co-supervisor
2013/03/01 - 2014 Pedro Velez, Biomedical Engineering Instituto Superior Tecnico, Univesidade de Lisboa, Internationalization of Molecular Medicine Companies - A Case Study
Supervisor
2012/03/01 - 2013 Catarina Silveira, Biologia Molecular e Genética, Faculdade de Ciências da Universidade de Lisboa, Nephrotic syndrome in childhood: genotype - phenotype association studies and screening for novel mutations
Supervisor

Jury of academic degree

Topic
Role
Candidate name (Type of degree)
Institution / Organization
2017/07/17 Member (1st examiner) of the Jury of Ph. D. thesis defense: Teresa Fidalgo, University of Coimbra, Faculdade de Ciencias e Tecnologia, Von Willebrand factor and ADAMTS13 – Duality in hemorrhagic and thrombotic disease, 17.07.2017 Teresa Fidalgo (PhD)
2016/06/03 Member (1st examiner) of the Jury of Ph. D. thesis defense: Susana Ferreira, Univ. Porto, Faculty of Medicine, Characterization of GLA gene mutations in young Portuguese stroke patients, 03.06.2016 Susana Ferreira (PhD)

Association member

Society Organization name Role
2018/09/01 - Current Sociedade Portuguesa de Genética Humana (SPGH) Association member, recently invited to scientific committee
2006/01/01 - Current European Society of Human Genetics Society member

Conference scientific committee

Conference name Conference host
2020/11/01 - Current 24ª Reunião da SPGH Portuguese Society of Human Genetics

Course / Discipline taught

Academic session Degree Subject (Type) Institution / Organization
2012/03/01 - Current Genetics Universidade de Lisboa Faculdade de Medicina, Portugal
2012/03/01 - Current Masters course in Metabolic Diseases Universidade de Lisboa Faculdade de Medicina, Portugal
2012/03/01 - Current Cellular & Molecular Biology, Cellular & Human Development & Genetics Universidade de Lisboa Faculdade de Medicina, Portugal
2012/03/01 - Current Pharmacogenetics Universidade de Lisboa Faculdade de Medicina, Portugal

Mentoring / Tutoring

Topic Student name
2021/03/01 - Current Cybersickness as a Virtual Reality side effect: a retrospective study Fábio Remédios Duque
Distinctions

Other distinction

2014 Spitzer Visiting Scholar Grant
2013 Premio Roche - Yearly Investigation Grant of the Portuguese Society of Nephrology
Sociedade Portuguesa de Nefrologia, Portugal
2011 Best presentation: D Brito, G Miltenberger-Miltenyi, D Silva, N Diogo, H Madeira. Hypertrophic cardiomyopathy: clinical aspects of 7 novel missense mutations in MYBPC3 gene.
2010 3rd best presentation award: Análise Genética da Síndrome Nefrótica Congénita – primeiros resultados e descrição de quatro novas mutações.
2010 Best Portuguese presentation award: Pesquisa do Gene NPHS2 em Crianças com Glomerulosclerose Focal e Segmentar – Descrição de Duas Novas Mutações.
2006 Yearly Scientific Award
2004 Austrian-Hungarian Research Foundation Grant (OMAA 58öu3)
1998 Research Fellowship of Graduiertenkolleg for Experimental Kidney- and Circulation Research
1998 Grant of Deutscher Akademischer Austausch Dienst (DAAD)
1997 TEMPUS Grant
European Union, Belgium